[Clinical trials of solcoseryl in the treatment of parodontium diseases].
The effect of Solcoseryl on the clinical state of the parodontium was assessed in 26 patients aged from 18 to 57 years with the diagnosis of deep parodontopathies. Each patient received 30 ampoules of 2 ml of Solcoseryl for one course of the treatment. Submucous injections of the drug near the teeth 13, 23, 33 and 43 were done as follows: during the first 10 days one ampoule daily, then 10 injections every other day, and 10 injections at three-day intervals. The condition of the parodontium was assessed before and after the treatment by means of the PI, GI, GBI and teeth mobility indices, and measurements of the depth of gingival pouches--K, and volume of fluid in pouches SFFR according to Brill. The therapeutic method applied in these cases had a good effect on reduction of gingivitis, bleeding and volume of secreted pouch fluid but had only a small effect on teeth mobility and depth of gingival pouches.
Jedrzejewska
T
T
Bałczewska
E
E
Peterson
R
R
Urbaniak
B
B
Ostrowska
B
B
D000183:Actihaemyl / Q000627:therapeutic use*; D000328:Adult; D005888:Gingival Pocket / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D010510:Periodontal Diseases / Q000188:drug therapy*; D010512:Periodontal Index; D014086:Tooth Mobility
D000183:Actihaemyl
Ocena kliniczna solcoserylu w leczeniu chorób przyzebia.